<DOC>
	<DOCNO>NCT01795183</DOCNO>
	<brief_summary>Primary Objective : To evaluate effectiveness amisulpride Chinese patient schizophrenia Secondary Objective : To evaluate overall safety amisulpride Chinese patient schizophrenia .</brief_summary>
	<brief_title>Effectiveness Safety Amisulpride Chinese Patients With Schizophrenia</brief_title>
	<detailed_description>The study duration subject include 8-week treatment period 3 follow-up visit .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Sultopride</mesh_term>
	<mesh_term>Sulpiride</mesh_term>
	<criteria>Inclusion criterion : Satisfying International Classification Disease10 ( ICD ) diagnostic criterion schizophrenia ; Positive Negative Syndrome Scale ( PANSS ) total score â‰¥ 60 Exclusion criterion : Refractory schizophrenia Patients treat sufficient clozapine minimum period 68 week without improvement ; Participation another clinical trial within last month ; Patients previously currently treat amisulpride ; Patients receive clozapine within past 1 month treat longacting formulation antipsychotic medication within past 2 month ; Patients receive electric convulsive therapy physical therapy within past 1 month ; Patients coexist severe systemic disease ; The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>